These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Impact of 1p/19q codeletion and histology on outcomes of anaplastic gliomas treated with radiation therapy and temozolomide. Speirs CK; Simpson JR; Robinson CG; DeWees TA; Tran DD; Linette G; Chicoine MR; Dacey RG; Rich KM; Dowling JL; Leuthardt EC; Zipfel GJ; Kim AH; Huang J Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):268-76. PubMed ID: 25636755 [TBL] [Abstract][Full Text] [Related]
5. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches. Juratli TA; Schackert G; Krex D Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764 [TBL] [Abstract][Full Text] [Related]
6. Efficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells. Kato T; Natsume A; Toda H; Iwamizu H; Sugita T; Hachisu R; Watanabe R; Yuki K; Motomura K; Bankiewicz K; Wakabayashi T Gene Ther; 2010 Nov; 17(11):1363-71. PubMed ID: 20520650 [TBL] [Abstract][Full Text] [Related]
7. Surgery, radiotherapy and temozolomide in treating high-grade gliomas. Parlato C; Barbarisi M; Moraci M; Moraci A Front Biosci; 2006 May; 11():1280-3. PubMed ID: 16368514 [TBL] [Abstract][Full Text] [Related]
8. A combination of IFN-beta and temozolomide in human glioma xenograft models: implication of p53-mediated MGMT downregulation. Natsume A; Wakabayashi T; Ishii D; Maruta H; Fujii M; Shimato S; Ito M; Yoshida J Cancer Chemother Pharmacol; 2008 Apr; 61(4):653-9. PubMed ID: 17564708 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression. Yu Z; Chen Y; Wang S; Li P; Zhou G; Yuan Y Cancer Lett; 2018 Aug; 428():77-89. PubMed ID: 29705182 [TBL] [Abstract][Full Text] [Related]
10. Evidence-based adjuvant therapy for gliomas: current concepts and newer developments. Khan MK; Hunter GK; Vogelbaum M; Suh JH; Chao ST Indian J Cancer; 2009; 46(2):96-107. PubMed ID: 19346643 [TBL] [Abstract][Full Text] [Related]
11. Effect of IFN-beta on human glioma cell lines with temozolomide resistance. Yoshino A; Ogino A; Yachi K; Ohta T; Fukushima T; Watanabe T; Katayama Y; Okamoto Y; Naruse N; Sano E Int J Oncol; 2009 Jul; 35(1):139-48. PubMed ID: 19513561 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of temozolomide is correlated with 1p loss and methylation of the deoxyribonucleic acid repair gene MGMT in malignant gliomas. Ishii D; Natsume A; Wakabayashi T; Hatano H; Asano Y; Takeuchi H; Shimato S; Ito M; Fujii M; Yoshida J Neurol Med Chir (Tokyo); 2007 Aug; 47(8):341-9; discussion 350. PubMed ID: 17721049 [TBL] [Abstract][Full Text] [Related]
13. Interferon-α/β enhances temozolomide activity against MGMT-positive glioma stem-like cells. Shen D; Guo CC; Wang J; Qiu ZK; Sai K; Yang QY; Chen YS; Chen FR; Wang J; Panasci L; Chen ZP Oncol Rep; 2015 Nov; 34(5):2715-21. PubMed ID: 26329778 [TBL] [Abstract][Full Text] [Related]
14. A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas. Kumthekar P; Grimm S; Chandler J; Mehta M; Marymont M; Levy R; Muro K; Helenowski I; McCarthy K; Fountas L; Raizer J J Neurooncol; 2017 Jul; 133(3):589-594. PubMed ID: 28510787 [TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy. Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493 [TBL] [Abstract][Full Text] [Related]
16. Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial. Malmström A; Poulsen HS; Grønberg BH; Stragliotto G; Hansen S; Asklund T; Holmlund B; Łysiak M; Dowsett J; Kristensen BW; Söderkvist P; Rosell J; Henriksson R; Acta Oncol; 2017 Dec; 56(12):1776-1785. PubMed ID: 28675067 [TBL] [Abstract][Full Text] [Related]
17. Treatment updates regarding anaplastic oligodendroglioma and anaplastic oligoastrocytoma. Khan KA; Abbasi AN; Ali N J Coll Physicians Surg Pak; 2014 Dec; 24(12):935-9. PubMed ID: 25523732 [TBL] [Abstract][Full Text] [Related]
18. O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort. Pollack IF; Hamilton RL; Sobol RW; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL J Clin Oncol; 2006 Jul; 24(21):3431-7. PubMed ID: 16849758 [TBL] [Abstract][Full Text] [Related]
19. [A molecular classification system for anaplastic glioma]. Jiang HH; Ren XH; Zhang Z; Lin S Zhonghua Wai Ke Za Zhi; 2013 Dec; 51(12):1104-9. PubMed ID: 24499721 [TBL] [Abstract][Full Text] [Related]
20. The PI3K inhibitor GDC-0941 enhances radiosensitization and reduces chemoresistance to temozolomide in GBM cell lines. Shi F; Guo H; Zhang R; Liu H; Wu L; Wu Q; Liu J; Liu T; Zhang Q Neuroscience; 2017 Mar; 346():298-308. PubMed ID: 28147244 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]